STENNACK SURGERY
THE OLD STENNACK SCHOOL, STENNACK, ST. IVES
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 28 | 34 | 82.4% | |
| HF 4 | 2011 | 41 | 56 | 73.2% | |
| HF 4 | 2012 | 41 | 43 | 95.3% | |
| HF 4 | 2013 | 48 | 52 | 92.3% | |
| HF004 | 2014 | 36 | 40 | 90.0% | |
| HF004 | 2015 | 33 | 37 | 89.2% | |
| HF004 | 2016 | 36 | 42 | 85.7% | |
| HF004 | 2017 | 41 | 46 | 89.1% | |
| HF004 | 2018 | 45 | 45 | 100.0% | |
| HF004 | 2020 | 46 | 53 | 86.8% | |
| HF006 | 2021 | 68 | 72 | 94.4% | |
| HF006 | 2022 | 64 | 64 | 100.0% | |
| HF006 | 2023 | 98 | 98 | 100.0% |
